Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,019.00. The company's market cap stands at 967.61B, with a P/E ratio of 50.63 and a dividend yield of 58.6%.
On 2026-01-29, Eli Lilly(LLY) stock moved within a range of $1,018.00 to $1,040.00. With shares now at $1,019.00, the stock is trading +0.1% above its intraday low and -2.0% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 2.29M, versus its average volume of 2.97M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
TrumpRx — the government’s drug pricing initiative, which is at the center of the tariff deals the administration has reached with drugmakers since September —...
Repertoire Immune Medicines entered a strategic collaboration on Thursday with Eli Lilly and Co. (NYSE:LLY) to develop tolerizing therapies for multiple autoimm...
U.S. pharmaceutical giant Eli Lilly (LLY) has signed an agreement worth up to $1.12 billion with Seamless Therapeutics, a privately held German startup company...
Analyst ratings
75%
of 32 ratingsMore LLY News
Technology How Roche Hopes To Go Toe-To-Toe With Eli Lilly, Novo Nordisk In Obesity Licensing Roche (RHHBY) hopes to go toe-to-toe with Eli Lilly (LLY) and Novo...
This pharmaceutical giant is increasingly looking unstoppable. Artificial intelligence (AI) is impacting, and will eventually impact, nearly every sector and i...
Eli Lilly (NYSE:LLY) has entered a research collaboration with Seamless Therapeutics to develop gene editing based treatments for hearing loss. The company rec...
Key Points Eli Lilly's stock trades at more than 30 times forward earnings, which is a steep price to pay right now. Amgen is a much cheaper option by compari...
European pharmaceutical company Novo Nordisk (NVO) is spending twice as much as its U.S. rival Eli Lilly on weight-loss drug advertisements. Data from advertis...
Eli Lilly & Co. (LLY) shares traded lower Wednesday, even as the pharmaceutical giant announced a major partnership with German biotech Seamless Therapeutics Gm...
Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly (LLY) and Company to develop and commerciali...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.